Advertisement

Inpharma Weekly

, Volume 1572, Issue 1, pp 6–6 | Cite as

Epratuzumab plus rituximab make the cut with CHOP therapy for DLBCL

Clinical study
  • 4 Downloads

Keywords

Survival Rate Lymphoma Systemic Lupus Erythematosus Pilot Study Doxorubicin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2007

Personalised recommendations